Description
SITAGORA-M 500 is a combination antidiabetic tablet containing Sitagliptin Phosphate and Metformin Hydrochloride. It is prescribed for the management of Type 2 Diabetes Mellitus when combination therapy is considered appropriate.
Sitagliptin belongs to the DPP-4 inhibitor class, while Metformin belongs to the biguanide class of antidiabetic medicines. Together, they work through complementary mechanisms to support blood glucose control in suitable patients.
Composition
Sitagliptin Phosphate + Metformin Hydrochloride Tablets
The product is marketed under the brand SITAGORA-M 500. The exact individual strengths of Sitagliptin and Metformin should be confirmed from the approved product specification before publishing them on the website.
Uses and Indications
SITAGORA-M 500 may be prescribed for:
- Management of Type 2 Diabetes Mellitus
- Helping control high blood glucose levels
- Improving glycemic control
- Supporting insulin sensitivity
- Patients requiring combination antidiabetic therapy
- Supporting long-term diabetes management
The medicine should be used along with appropriate diet, exercise and lifestyle measures as advised by a healthcare professional.
Benefits of Sitagliptin + Metformin
The combination provides complementary approaches to blood glucose management:
- Helps improve blood glucose control
- Supports better glycemic management
- Combines two different antidiabetic mechanisms
- Sitagliptin supports glucose-dependent insulin secretion
- Metformin helps improve insulin sensitivity
- May be prescribed when single-drug therapy does not provide adequate glycemic control
How Does SITAGORA-M 500 Work?
Sitagliptin
Sitagliptin is a DPP-4 inhibitor. It increases the activity of incretin hormones, which helps support glucose-dependent insulin secretion and regulation of glucagon.
Metformin
Metformin primarily reduces glucose production by the liver and improves the body’s response to insulin.
Combination Action
By combining Sitagliptin and Metformin, SITAGORA-M 500 provides complementary mechanisms that can help improve glycemic control in appropriate patients with Type 2 Diabetes.
Dosage and Administration
The dosage of SITAGORA-M 500 should be determined by the treating physician based on the patient’s blood glucose levels, kidney function, medical history and other medications.
Take the medicine exactly as prescribed. Do not change the dosage or discontinue treatment without consulting your doctor.
Possible Side Effects
Possible side effects may include:
- Nausea
- Diarrhea
- Stomach discomfort
- Headache
- Dizziness
- Weakness or tiredness
If symptoms are severe or persistent, consult a qualified healthcare professional.
Precautions
Before taking Sitagliptin Phosphate and Metformin Hydrochloride Tablets, inform your doctor about your medical history and all medicines you are currently taking.
Patients with kidney or liver problems or other relevant medical conditions may require appropriate medical evaluation before and during treatment.
This is a prescription medicine and should be used only under medical supervision.
Product Details
| Parameter | Details |
|---|---|
| Brand Name | SITAGORA-M 500 |
| Composition | Sitagliptin Phosphate + Metformin Hydrochloride |
| Dosage Form | Tablets |
| Therapeutic Category | Antidiabetic |
| Indication | Type 2 Diabetes Mellitus |
| Prescription | Prescription Medicine |
| Strength | 500 mg designation; verify individual ingredient strengths |
| Pack Size | As per approved product pack |
| Marketer | Rapid Life Drugs & Healthcare |
Frequently Asked Questions
1. What is SITAGORA-M 500?
SITAGORA-M 500 is a combination antidiabetic tablet containing Sitagliptin Phosphate and Metformin Hydrochloride, prescribed for the management of Type 2 Diabetes Mellitus.
2. What is the composition of SITAGORA-M 500?
It contains Sitagliptin Phosphate and Metformin Hydrochloride.
3. What is SITAGORA-M 500 used for?
It is prescribed to help manage Type 2 Diabetes Mellitus and improve blood glucose control.
4. How does Sitagliptin work?
Sitagliptin inhibits the DPP-4 enzyme and helps incretin hormones remain active for longer, supporting glucose-dependent insulin secretion.
5. What is the role of Metformin?
Metformin primarily reduces glucose production by the liver and improves insulin sensitivity.
6. Can SITAGORA-M 500 be taken without a doctor’s advice?
No. It should be taken only according to the prescription and guidance of a qualified healthcare professional.
7. Is SITAGORA-M 500 suitable for every diabetes patient?
No. The suitability of the combination depends on factors such as kidney function, medical history, current treatment and blood glucose control. A doctor should determine whether it is appropriate.
8. What is the therapeutic category of SITAGORA-M 500?
SITAGORA-M 500 belongs to the antidiabetic therapeutic category and is used in the management of Type 2 Diabetes Mellitus.
